Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Consulting agrmnt
Appointed director
Rapid Therapeutic Science Laboratories, Inc. (RTSL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FORM OF SECOND AMENDMENT, WAIVER AND PURCHASE AGREEMENT, DATED AUGUST 22, 2023",
"FORM OF COMMON STOCK PURCHASE WARRANT"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/14/2023 8-K Quarterly results
05/17/2023 RW Form RW - Registration Withdrawal Request:
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/22/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/31/2022 8-K Quarterly results
05/11/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/16/2022 10-K Annual Report for the period ended December 31, 2021
02/01/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SECURITIES PURCHASE AGREEMENT DATED JANUARY 28, 2022",
"PROMISSORY NOTE DATED JANUARY 28, 2022"
01/21/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SECURITIES PURCHASE AGREEMENT DATED JANUARY 18, 2022",
"PROMISSORY NOTE DATED JANUARY 18, 2022"
01/18/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FIRST AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN"
01/14/2022 DEFA14C Form DEFA14C - Additional information statement materials, definitive:
01/14/2022 DEF 14C Form DEF 14C - Other definitive information statements:
12/30/2021 3/A Justin Scott Suggs (Director) has filed a Form 3/A on Rapid Therapeutic Science Laboratories, Inc.
12/30/2021 PRE 14C Form PRE 14C - Other preliminary information statements:
12/28/2021 4 Berrier Sean Paul (10% Owner) has filed a Form 4 on Rapid Therapeutic Science Laboratories, Inc.
Txns: Gifted 2,000,000 shares @ $0.26, valued at $520k
12/28/2021 4 Schmidt Donal Ray Jr. (CEO) has filed a Form 4 on Rapid Therapeutic Science Laboratories, Inc.
Txns: Gifted 2,000,000 shares @ $0.26, valued at $520k
11/10/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/12/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Rapid Therapeutic Science Laboratories to Present at the LD Micro Main Event Conference DALLAS, Oct. 06, 2021 -- Rapid Therapeutics Science Laboratories (“Rapid Therapeutic” or the “Company",
"POWERPOINT PRESENTATION"
09/27/2021 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
08/27/2021 3 Punzi Henry Anthony (Director) has filed a Form 3 on Rapid Therapeutic Science Laboratories, Inc.
08/25/2021 8-K Quarterly results
08/11/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/05/2021 8-K Quarterly results
08/05/2021 3 Justin Scott Suggs (Director) has filed a Form 3 on Rapid Therapeutic Science Laboratories, Inc.
07/26/2021 SC 13G Disciples of the Way Ministries reports a 6% stake in RAPID THERAPEUTIC SCIENCE LABORATORIES, INC.
06/01/2021 8-K Quarterly results
05/14/2021 10-Q Quarterly Report for the period ended March 31, 2021
04/14/2021 8-K Quarterly results
04/02/2021 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
03/16/2021 10-KT Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy